Progress in primary aldosteronism

Hormone and Metabolic Research

Volumn 42, Issue 6, 2010, Pages 371-373

  Reincke, M ^a   Beuschlein, F ^a   Bidlingmaier, M ^a   Funder, J W ^b   Bornstein, S R ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MONASH MEDICAL CENTRE   (Australia)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MINERALOCORTICOID ANTAGONIST; POTASSIUM CHANNEL; POTASSIUM CHANNEL TASK1; POTASSIUM CHANNEL TASK3; THYROTROPIN; UNCLASSIFIED DRUG;

ADRENALECTOMY; ALDOSTERONE RELEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EDITORIAL; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HYPERTENSION; HYPOKALEMIA; MASS SCREENING; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHEOCHROMOCYTOMA; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; DIAGNOSTIC TECHNIQUES, ENDOCRINE; ENDOCRINOLOGY; HUMANS; HYPERALDOSTERONISM; HYPERTENSION;

EID: 77952911923     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1253417     Document Type: Editorial

References (17)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM. Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008 93 3266-3281
2. Gomez-Sanchez CE, Rossi GP, Fallo F, Mannelli M. Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res 2010 42 374-381
3. Quack I, Vonend O, Rump LC. Familial hyperaldosteronism I-III. Horm Metab Res 2010 42 424-428
4. Mazzuco TL, Grunenwald S, Lampron A, Bourdeau I, Lacroix A. Aberrant hormone receptors in primary aldosteronism. Horm Metab Res 2010 42 416-423
5. Bandulik S, Penton D, Barhanin J, Warth R. TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation. Horm Metab Res 2010 42 450-457
6. Beuschlein F. Animal models of primary aldosteronism. Horm Metab Res 2010 42 446-449
7. Tomaschitz A, Pilz S. Aldosterone to renin ratio a reliable screening tool for primary aldosteronism? Horm Metab Res 2010 42 382-391
8. Hannemann A, Friedrich N, Lüdemann J, Vlzke H, Rettig R, Peters J, Reincke M, Dring A, Nauck M, Wallaschofski H. Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based study of health in Pomerania (SHIP-1). Horm Metab Res 2010 42 392-399
9. Manolopoulou J, Gerum S, Mulatero P, Rossignol P, Plouin PF, Reincke M, Bidlingmaier M. Salivary aldosterone as a diagnostic aid in primary aldosteronism. Horm Metab Res 2010 42 400-405
10. Mulatero P, Monticone S, Bertello C, Mengozzi G, Tizzani D, Iannaccone A, Veglio F. Confirmatory tests in the diagnosis of primary aldosteronism. Horm Metab Res 2010 42 406-410
11. Auchus RJ, Wians FH Jr, Anderson ME, Dolmatch BL, Trimmer CK, Josephs SC, Chan D, Toomay S, Nwariaku FE. What we still do not know about adrenal vein sampling for primary aldosteronism. Horm Metab Res 2010 42 411-415
12. Quinkler M, Born-Frontsberg E, Fourkiotis VG. Comorbidities in primary aldosteronism. Horm Metab Res 2010 42 429-434
13. Schupp N, Queisser N, Wolf M, Kolkhof P, Brfacker L, Schfer S, Heidland A, Stopper H. Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists. Horm Metab Res 2010 42 458-465
14. Catena C, Colussi G, Di Fabio A, Valeri M, Marzano L, Uzzau A, Sechi LA. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism. Horm Metab Res 2010 42 440-445
15. Reincke M, Meisinger C, Holle R, Quinkler M, Hahner S, Beuschlein F, Bidlingmaier M, Seissler J, Endres S. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's registry. Horm Metab Res 2010 42 435-439
16. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 2003 100 14211-14216
17. Doi M, Takahashi Y, Komatsu R, Yamazaki F, Yamada H, Haraguchi S, Emoto N, Okuno Y, Tsujimoto G, Kanematsu A, Ogawa O, Todo T, Tsutsui K, van der Horst GT, Okamura H. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2010 16 67-74